Prognostic Significance of CD47 and DHX9 in Metastatic Rectal Cancer

Background/Objectives: The prognosis of metastatic rectal cancer remains poor, and few reliable prognostic biomarkers are available. DHX9 and CD47 have been implicated in colorectal cancer biology, but their prognostic value in metastatic disease remains unclear. We evaluated the associations of DHX9 and CD47 expression with clinical characteristics, molecular markers and overall survival.

Methods